Factors Predicting Rubella Vaccination and Antibody in Pregnant Women in Japan: A Report from Pregnant Women Health Initiative.
Japan
pregnant women
pregnant women health initiative
rubella
rubella antibody
rubella vaccine
vaccination status
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
19 Apr 2022
19 Apr 2022
Historique:
received:
20
03
2022
revised:
13
04
2022
accepted:
15
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
This study aimed to identify the factors predicting rubella vaccination status based on self-reported data and the presence of sufficient rubella antibody titers in pregnant women in Japan. We used the results of the nationwide questionnaire survey conducted at obstetric facilities in the Pregnant Women Health Initiative Project (PWHI), with 23 participating hospitals recruiting pregnant women from June 2018-November 2019. We extracted age, the number of deliveries, educational level, household income, pre-pregnancy smoking, and knowledge of rubella from questionnaires and medical records. We analyzed the association of rubella vaccination status and antibodies with each of these factors. We found that the number of previous deliveries, educational level, annual household income, smoking before pregnancy, and knowledge of rubella were factors predicting self-reported rubella vaccination status, while age and the number of previous deliveries were identified as factors predicting the presence of sufficient rubella antibody titers (32 folds or higher). Women considering pregnancy should be immunized against rubella to prevent congenital rubella syndrome in the future. Furthermore, social policies are needed to strongly encourage vaccination, especially for all citizens who were not given the opportunity or missed the chance to be vaccinated against rubella.
Identifiants
pubmed: 35632393
pii: vaccines10050638
doi: 10.3390/vaccines10050638
pmc: PMC9147004
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Health Labour and Welfare
ID : H30-SUKOYAKA-IPPAN-005
Références
Ann Ig. 2019 Mar-Apr;31(2 Supple 1):65-71
pubmed: 30994165
J Travel Med. 2019 Sep 2;26(6):
pubmed: 31259366
Int J Infect Dis. 2017 Sep;62:112-118
pubmed: 28739423
Front Public Health. 2021 Sep 13;9:741178
pubmed: 34589465
J Obstet Gynaecol Res. 2008 Apr;34(2):168-73
pubmed: 18412777
Infect Control Hosp Epidemiol. 2007 May;28(5):564-9
pubmed: 17464916
Yakugaku Zasshi. 2020;140(7):901-904
pubmed: 32612053
Vaccine. 2018 Jan 11;36 Suppl 1:A35-A42
pubmed: 29307368
Lancet Infect Dis. 2018 Jul;18(7):713-714
pubmed: 29976516
Vaccine. 2020 Sep 11;38(40):6344-6345
pubmed: 32768334
Jpn J Infect Dis. 2021 Jul 21;74(4):337-343
pubmed: 33390430
BMC Public Health. 2021 Feb 4;21(1):292
pubmed: 33541317
Int J Clin Pract. 2021 Jun;75(6):e14156
pubmed: 33743553
PLoS One. 2015 Jun 09;10(6):e0129900
pubmed: 26057740
Vaccine. 2016 Apr 7;34(16):1971-4
pubmed: 26469722
Environ Health Prev Med. 2021 Aug 11;26(1):77
pubmed: 34380430
Lancet. 2015 Jun 6;385(9984):2297-307
pubmed: 25576992
PLoS One. 2020 Aug 14;15(8):e0237312
pubmed: 32797060
Int J Infect Dis. 2016 Aug;49:196-201
pubmed: 27196370